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ABSTRACT 
The objective of the present study was to study the effect of hydrophilic polymers on sustained release of metformin hydrochloride from 
tablets. Compatibility was studied by Fourier transform infrared spectroscopy. The tablets were prepared by direct compression technique 
using Xanthan gum alone and in combination with HPMC as release retardant. Di calcium phosphate was used as diluent. The prepared matrix 
tablets were evaluated for their physicochemical parameters such as weight variation, hardness, friability, content uniformity and in-vitro 
dissolution. Pre and post compression parameters were evaluated and all the parameters were found within the limit. The drug release data 
were subjected to different models in order to evaluate release kinetics and mechanism of drug release. Formulation F5 was selected as best 
formulation. The dissolution of formulation F5 can be described by first order kinetics with fickian diffusion as the release mechanism.  
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INTRODUCTION  
Diabetes is one of the major causes of death and disability in 
the world. Diabetes is a condition that impairs the body’s 
ability to process blood glucose 1. Diabetes mellitus is a 
heterogeneous metabolic disorder characterized by the 
presence of hyperglycemia due to impairment of insulin 
secretion, defective insulin action or both 2. Diabetes mellitus 
can be classified into two main types. First is type I or 
juvenile diabetes which is also called as insulin dependent 
diabetes and second is type II or non insulin dependent 
diabetes mellitus. Type II diabetes is most common type of 
diabetes, according to the national institute of diabetes. The 
type II diabetes mellitus usually develops more in the adult 
age, affecting mainly the elderly and obese individuals. 
Metformin hydrochloride is a first line biguanide 
hypoglycemic agent used in the treatment of non insulin 
dependent diabetes mellitus, not responding to dietary 
modification. It does not produce lactic acidosis. Metformin 
improves glucose tolerance by lowering both basal and post 
prandial glucose by decreasing intestinal absorption of 
glucose, decreasing hepatic glucogenesis, lipogenesis and 
glucose uptake by adipocytes and muscle cells3. It is on the 
world health organization’s list of essential medicines the 
most effective and safe medicines needed in a healthy 
system. Its oral bioavailability is 50-60% and its average 
elimination half life is 6.2 hours, require repeated 
administrations of high doses to maintain effective plasma 
concentrations,  thus reducing patient compliance and 
enhancing the incidence of side effects.4-7 Many studies have 
reported that the oral absorption of metformin is mainly 
confined to the small intestine. This could be attained by the 
development of sustained release matrix tablets. 
Administration of sustained release tablets of metformin 
hydrochloride could reduce the dosing frequency and 
improves patient compliance 8, 9. 
Sustained release oral drug delivery systems are designed to 
achieve therapeutically effective concentrations of drug in 
systemic circulation over an extended period of time. Matrix 
systems are most popular among oral drug delivery systems 
because of their simplicity, low cost, ease of manufacturing, 
reduced dose frequency, improved patient compliance and 
efficacy 10. In a matrix system drug was dispersed as solid 
particles within a porous matrix former of a hydrophilic or 
hydrophobic polymer, drug release from the tablet was 
controlled by the nature and properties of polymer. 
Hydrophilic polymers such as xanthan gum and HPMC which 
have been utilized individually or in blends to design 
hydrophilic matrix tablets to achieve controlled drug 
delivery dosage forms generally have reduced frequency of 
dosing, increased compliance, increased therapeutic effect, 
reduced side-effects, improved tolerability and reduced cost 
of treatment. Blending different hydrophilic polymers 
improves the physicochemical and release modifying 
properties of the resultant polymer leading to the design and 
Eswaraiah et al                                                                                                           Journal of Drug Delivery & Therapeutics. 2019; 9(4):24-29 
ISSN: 2250-1177                                                                                  [25]                                                                                 CODEN (USA): JDDTAO 
formation of an optimized controlled-release product and 
the proper selection of polymers can help control the release 
profile of drugs. Hydrophilic matrix systems undergo 
swelling followed by gel formation, erosion and dissolution 
in aqueous media. In addition, such systems can sustain high 
drug loading 11. 
The aim of this study was to prepare matrix tablets of 
metformin hydrochloride using varying proportions of the 
HPMCK4M, HPMCK15 and xanthan gum. 
MATERIALS &METHODS 
Materials 
Metformin hydrochloride was purchased from Yarrow 
chemical Ltd., (Mumbai, India)., HPMCK4M, HPMCK15M, 
Xanthan gum dicalcium phosphate purchased from research 
lab (Mumbai, India) talc and magnesium stearate were 
purchased from Aman scientific traders Vijayawada (India). 
All other chemicals, solvents and reagents used were of 
analytical grade. 
Methods 
Drug excipient compatibility study 
Infrared spectra of the pure drug and drug with polymers 
were recorded on a fourier transform infra red 
spectrophotometer. The disc method was employed to study 
possible interactions between drug and selected polymers. 
Infrared spectrum was taken by scanning the sample in KBr 
(IR grade) discs and analyzed over a wave number range of  
4000-400  cm-1.Transmittance spectra were recorded. 
Preparation of matrix tablets 
Matrix tablets of metformin hydrochloride were prepared by 
direct compression technique using varying proportions of 
hydrophilic polymers alone and in combination. The 
composition of matrix tablets is given in table -1. All the 
ingredients were individually passed through a 60 mesh 
sieve, except glidant and lubricant. For each formulation 
required quantities of metformin hydrochloride, polymer 
(HPMC, xanthan gum), diluents (dicalcium phosphate) were 
accurately weighed according to the composition and mixed 
in a polybag for about 30 to 45 minutes. The obtained blend 
was lubricated with talc and magnesium stearate for another 
5 minutes. The appropriate amount of the mixture was 
weighed and then compressed using 12 station rotary tablet 
press (CEMACH, Ahmedabad, India) equipped with 12 mm 
flat faced punches at a constant compression force required 
to produce hardness of tablets about 5-7 kg/ cm 2. All the 
tablets were stored in airtight containers for further use.  
 
Table 1- Composition of matrix tablets of metformin hydrochloride 
Ingridients per tablets 
(mg) 
Composition (mgs) of the prepared formulation 
F1 F2 F3 F4 F5 F6 F7 F8 F9 
Metformin HCL 500 500 500 500 500 500 500 500 500 
Xanthan gum 250 300 350 - - - - - - 
XG+HPMCK4M - - - 250 300 350 - - - 
XG+HPMCK15M - - - - - - 250 300 350 
Di calcium phosphate 230 180 130 230 180 130 230 180 130 
Magnesium stearate 5 5 5 5 5 5 5 5 5 
Talc 5 5 5 5 5 5 5 5 5 
 
Micromeritic properties of blended powder 12 
Angle of Repose  
The frictional forces in a loose powder can be measured by 
the angle of repose. Angle of repose is defined as maximum 
angle possible between the surface of a pile of the powder 
and the horizontal plane. The angle of repose was 
determined by the fixed funnel method. Angle of repose was 
calculated using the following equation. 
        
 
 
 
Where, θ = angle of repose, 
h = height of the pile, 
r = radius of the pile base 
Compressibility Index  
The Carr’s compressibility index of the powder blend is 
defines as  
                             
                           
              
     
 Bulk density is the ratio of mass of powder to the bulk 
volume. Tapped density is the ratios of mass of powder to 
the tapped volume. 
 
 
Evaluation of matrix tablets13 
The prepared matrix tablets were evaluated for their 
physical properties like weight variation, hardness and 
friability and drug content. 
Weight variation 
Twenty tablets of each formulation were weighed 
individually using an electronic weighing balance. The 
average weight was calculated and individual tablet weight 
was compared with average weight. 
Hardness Friability 
The hardness of six tablets was measured by Monsanto 
hardness tester. Hardness of tablets was measured in terms 
of kg/cm 2  
Friability 
Friability of tablets was measured by using Roche friabilator. 
Ten tablets were accurately weighed and placed in the 
friabilator and operated for 100 revolutions. The tablets 
were dedusted and reweighed. The friability was calculated 
using following equation. 
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Uniformity of drug content 
Ten tablets were weighed from each formulation and 
triturated in mortar to a fine powder. Powder equivalent to 
500 mg of metformin hydrochloride was extracted in 100 ml 
of pH 6.8 phosphate buffer and liquid was filtered. The drug 
content was determined by measuring the absorbance at 
233 nm (using UV-Visible spectrophotometer, Lab India) 
after appropriate dilution with pH 6.8 phosphate buffer. The 
drug content was determined using calibration curve. 
In vitro dissolution study 
The in-vitro dissolution study of matrix tablets of metformin 
hydrochloride was performed using USP type II dissolution 
apparatus (DBK) at a rotational speed of 50 rpm. In order to 
simulate gastrointestinal transit conditions, the tablets were 
subjected to different dissolution media. The dissolution 
medium used were  900 ml of pH 1.2 buffer for first two 
hours and pH 6.8 phosphate buffer for next ten hours. The 
dissolution medium was maintained at a temperature of 37 
± 0.50 C.  At predetermined time intervals, 5 ml of the sample 
solution was withdrawn from the dissolution apparatus and 
the samples were replaced with fresh dissolution medium to 
maintain sink conditions. The collected samples were 
filtered through a 0.45 µm membrane filter and the drug 
content in each sample was analyzed by measuring 
absorbance at 233 nm after suitable dilution using UV-
spectrophotometer (LABINDIA). Cumulative percentage of 
drug release was calculated using equation obtained from a 
calibration curve. 
In- vitro drug release kinetic study 
To study the release mechanism of metformin hydrochloride 
from the sustained release matrix tablets, the invitro drug 
release data were fitted to the following the mathematical 
models: 
Zero order   Qt = Q0+ k0 t  (1) 
First order  log C= log C0 – k1t/20303 (2) 
Higuchi    Qt = kh t ½  (3) 
Korsmeyer – Peppas  Qt/Qα =kp t n   (4) 
Hixon- Crowell cube root (W01/3 –Wt1/3) = kht (5) 
Where Q0, Qt and Qα are the amounts of drug dissolved 
initially, at time t and at time infinite. C0 and C are the 
concentrations of drug initially and at time t, W0 and Wt are 
the amounts of drug in the pharmaceutical dosage form 
initially and at time t and k0, k1, kh and kp refer to the rate 
constants obtained from the linear curves of the respective 
models. n is the diffusional exponent that characterizes the 
mechanism of drug release. The values of the coefficient 
were calculated using regression analysis between log Qt/Qα 
and log time. The diffusional exponent n value was obtained 
from the slope of the regression equation and kp was 
calculated from antilog of the intercept value. 
If the value of n for a cylinder is < 0.45 it suggests the Fickian 
release ( diffusion controlled), if n > 0.45 and < 0.89 it is non 
– Fickian release ( diffusion and polymer relaxation), 0.89 is 
case II release ( only relaxation and swelling) and > 0.89 it 
suggests super case II release (relaxation and erosion) for 
swellable systems 
 For cylindrical systems like tablets, the n values of 
0.45 and 0.89 represent pure diffusion or erosion release 
respectively14. 
RESULTS AND DISCUSSION 
Powder characterization  
The powder mixture of all the formulations were evaluated 
for angle of repose, bulk density, tapped density, 
compressibility index and their values were shown in table 
2. The bulk densities and tapped densities were 0.78±0.01 to 
0.81±0.03 g/cm3 and 0.88±0.02 to 0.92±0.01 g/cm3 
respectively. Powder blend indicated good flow properties 
with an angle of repose values ranging from 29 to 330.  The 
Carr’s compressibility index for all the formulations were 
found to be less than 13 %, which indicates that the powder 
mixture has good flow properties. Hausner’s ratio was also 
calculated, the ration was ranged between 1.11 and 1.15.
 
Table 2: Micromeritic properties of formulation blends 
Formulation 
Bulk density 
(gm/cm3)* 
Tapped 
density 
(gm/cm3)* 
Compressibility 
index (%) 
Hausner’s 
ratio 
Angle of 
repose( 0) 
F1 0.79±0.01 0.88±0.02 11.02 1.12 30.32 
F2 0.78±0.02 0.89±0.01 12.30 1.14 29.96 
F3 0.79±0.01 0.90±0.02 12.20 1.13 32.68 
F4 0.80±0.03 0.90±0.01 11.27 1.12 31.54 
F5 0.78±0.01 0.88±0.03 11.36 1.14 29.85 
F6 0.81±0.03 0.92±0.01 12.57 1.14 32.42 
F7 0.78±0.03 0.90±0.03 12.83 1.15 30.64 
F8 0.79±0.02 0.88±0.02 10.22 1.11 31.36 
F9 0.80±0.02 0.91±0.02 12.08 1.13 32.52 
*All values are expressed as mean ± SD, n=3 
Evaluation of physical parameters 
Sustained release matrix tablets of metformin hydrochloride 
were prepared by direct compression technique. Total nine 
formulations were prepared. The tablet weight variation, 
hardness, friability and content uniformity for each 
formulation are shown in table 3. The weight variation test 
indicated that the percentage deviation of all tablet 
formulations was found to be within pharmacopoeial 
acceptable limit. The hardness of all the tablets was within 
the range of 5.24±0.09 to 6.46±0.12 kg/cm2. The percentage 
weight loss in the friability test was found to be below 0.8 % 
in all the cases indicated that all the tablets had good 
mechanical strength.  The drug content in all the batches was 
determined by measuring absorbance of sample at 233 nm 
using double beam UV spectrophotometer (LABINDIA).  The 
content uniformity among different formulations was found 
to be higher and the drug content was more than 98% which 
indicates uniform drug distribution in all the formulations. 
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Table-3: Physical properties of metformin hydrochloride matrix tablets 
Formulation Weight variation 
(mg)* 
Hardness 
(kg/cm2)# 
Friability (%) Content uniformity 
(%) 
F1 988.89±1.62 5.24±0.09 0.76 98.92 
F2 989.64±1.43 5.56±0.13 0.72 99.68 
F3 989.57±1.54 5.72±0.12 0.70 98.23 
F4 988.75±1.46 6.24±0.08 0.64 101.36 
F5 989.23±1.82 6.45±0.13 0.68 99.86 
F6 988.29±1.56 6.46±0.12 0.67 100.16 
F7 989.38±1.67 6.24±0.14 0.69 99.74 
F8 989.65±1.72 6.32±0.07 0.65 98.86 
F9 989.62±1.88 6.36±0.08 0.59 99.75 
*All values are expressed as mean ± SD, *n=20; #n=6. 
In vitro dissolution study 
Metformin hydrochloride release from the matrix tablets was 
studied for first two hours in pH 1.2 buffer and the next ten 
hours in pH 6.8 phosphate buffer. Total nine formulations 
were made with Xanthan gum alone and combination of 
xanthan gum with HPMCK4 and HPMCK15 in different ratios. 
The results of dissolution studies indicated that the first 
three formulations with Natural hydrophilic polymer, 
Xanthan gum alone released 46.82, 40.36 and 35.85% of 
drug at the end of 2 h and 98.42, 85.64 and 76.84% of drug at 
the end of 6 h. Formulations containing HPMCK4M in 
combination with xanthan gum released 37.36, 28.36 and 
26.36 % at the end of 2 h and 99.82, 98.63 and 95.66 % at the 
end of 12 h. Formulations containing HPMCK15M in 
combination with xanthan gum released 30.69, 24.83 and 
19.38 % at the end of 2 h and 98.58, 90.43 and 82.26 % at the 
end of 12 h. Marketed formulation Glycomet from USV 
showed 23.24% at 2h and 98.48% at 12h. The comparative 
dissolution profile of all the formulations is given in fig.-1. 
The results shown in fig.- 1 indicate that the release rate of 
metformin hydrochloride from all the sustained release 
matrix tablets was dependent on concentration of release 
retardant contained in the tablet. The drug release rate was 
decreased from the tablets as the concentration of release 
retardant was increase. Xanthan gum alone could not control 
the release of metformin hydrochloride from the tablets 
because burst release was observed due to high dose of drug. 
Two grade of hydroxyl propyl methyl cellulose could control 
the drug release when combined with high molecular weight 
xanthan gum up to 12 h. This may be due to the formation of 
thick gel layer around the tablets by quick hydration of 
xanthan gum. These results indicated that the Xanthan gum 
could control the release of metformin hydrochloride up to 
12 hrs when it combined with hydroxy propyl methyl 
cellulose (semi synthetic).  
 
 
Fig.- 1: Comparative in-vitro dissolution profile of all the formulations mean ± SD, n=3. 
Analysis of release data 
The release data of matrix tablets were fitted into various 
mathematical models (zero order, first order, higuchi, 
Peppas and hixon crowel) to evaluate the kinetics and 
mechanism of drug release from the tablets. The model that 
best fits the release data is selected based on the correlation 
coefficient value in various models. The model that gives 
high R2 value considered as the best fit of the release data. 
The kinetic parameters for metformin hydrochloride release 
from the matrix tablets are shown in table 4. The results 
indicated that the drug release from the matrix tablets were 
followed first order kinetics. To evaluate drug release 
mechanism from the matrix tablets plots of percent drug 
released verses square root of time as per Higuchi’s equation 
were constructed. The invitro release profiles of drug from 
all the formulations could be best expressed by higuchi 
equation as the plots showed high linearity with correlation 
coefficient values were in the range of 0.988 to 0.998. 
Release of the drug from the matrix tablets containing 
hydrophilic polymers generally follows diffusion. Diffusion is 
related to drug transport from the matrix tablet into the 
dissolution fluid. To confirm the diffusion mechanism, the 
invitro data was fitted into Koresmeyer’s Peppas equation.  
For matrix tablets release exponent an ‘n’ value of near 0.5 
indicates diffusion control and an ‘n’ value of near 1 
indicates erosion or relaxation control. Intermediate values 
indicates that diffusion and erosion as the release 
mechanism. The release exponent ‘n’ values were found to 
be in the range of 0.39 -0.50 indicating that the fickian 
diffusion is the mechanism of drug release from the matrix 
tablets.
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Table 4: Correlation coefficients and release exponent n according to the different kinetic equations used for 
describing metformin hydrochloride release behavior from sustained release matrix tablets. 
Formulation Zero order First order Higuchi Peppas Hixon-
Crowell R2 n 
F1 0.865 0.923 0.998 0.999 0.42 0.975 
F2 0.839 0.922 0.987 0.991 0.39 0.974 
F3 0.894 0.935 0.993 0.993 0.45 0.983 
F4 0.890 0.942 0.998 0.999 0.46 0.984 
F5 0.833 0.933 0.993 0.997 0.50 0.947 
F6 0.894 0.935 0.993 0.993 0.45 0.983 
F7 0.897 0.818 0.990 0.993 0.43 0.934 
F8 0.917 0.979 0.995 0.996 0.51 0.984 
F9 0.963 0.987 0.988 0.992 0.50 0.990 
 
Drug excipient compatibility study 
Fourier transform infra red spectroscopy studies revealed 
that pure metformin hydrochloride and best formulation 
showed two typical bands at 3368.99 and 3289.11 cm–1 due 
to N-H primary stretching vibration and a band at 3151.40 
cm–1 due to N-H secondary stretching, a weak intensity band 
at 1058 cm -1 assigned to C-N stretching vibration and 
characteristics strong absorption bands at 1622.33 and 
1539.21 cm–1 assigned to C=N stretching vibrations. No 
significant shifts of reduction in intensity of the FTIR bands 
of metformin hydrochloride were observed as shown in 
figure 2. From the FTIR spectra shown in fig 2, it is very clear 
that there are no interactions between drug and excipients. 
All the peaks responsible for the active functional groups 
were present in the best formulation (F5). 
 
 
Fig.- 2 a) : FTIR spectra of pure metformin hydrochloride 
 
Fig.- 2 b) : FTIR spectra of metformin hydrochloride matrix tablet containing xanthan gum and HPMCK4 ( F5) 
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CONCLUSION 
Sustained release matrix tablets of metformin hydrochloride 
were prepared using different ratios of xanthan gum and 
HPMCK4 and HPMCK15 cellulose by direct compression 
method. The results of the present study demonstrates that 
the xanthan gum alone could not control the metformin 
hydrochloride release effectively for 12 hrs, where as when 
combined with HPMCK4 and HPMCK15M, it could control 
the release of metformin hydrochloride from their matrices. 
It is concluded that sustained release of metformin 
hydrochloride over a period of 12 hours was obtained with 
formulation (F-5) containing xanthan gum and HPMCK4. The 
mechanism of drug release from the matrix tablets was 
found to be diffusion controlled i.e fickian diffusion with first 
order kinetics. Sustained release matrix tablets of metformin 
hydrochloride can be expected to reduce the frequency of 
administration and decrease the dose dependent side effects 
associated with repeated administration of conventional 
metformin hydrochloride tablets. 
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